Fecal samples collected from 245 cats over a 6-month period were analyzed for the presence of Clostridium difficile. After culture on selective media, isolates were identified by a latex agglutination test, and the presence of toxin A and toxin B gene sequences was determined by polymerase chain reaction. Clostridium difficile was isolated from 23 (9.4%) of the cats, and 34.8% of that group were colonized with toxigenic strains. All of the cats colonized with toxigenic C. difficile had Ն1 of the risk factors (antibiotic use, antineoplastic therapy, immunosuppressive virus infection) associated with C. difficile infection in humans. Clostridium difficile was not found in any of the cats from a clinically healthy outpatient group of cats examined from the same hospital nor in cats from a specific-pathogen-free research colony on the same campus tested during the same time period. The data obtained in this study confirm the presence of C. difficile in cats at a veterinary teaching hospital. DNA fingerprinting analysis of these isolates allowed separation of the strains into 5 groups. Type 4 strain found in 7 cats was also recovered from the floor drain in the same hospital, suggesting a possible source of infection. Whether the organism is of clinical significance in diarrheal diseases of cats remains to be determined.
within the bowel, and the ability of the organism to adhere to colonic epithelium. 25 Hospital-acquired gastrointestinal infections are of particular concern for animals subjected to prolonged hospitalization or invasive procedures or those receiving immunosuppressive agents. The organisms most likely to be acquired at UC Davis at present by small animal patients include Salmonella spp. (usually S. krefeld), C. perfringens type A, C. difficile, and Enterobacter spp. (usually E. cloacae). 9, 10, 11 The purpose of the present study was to determine the prevalence of C. difficile in cats in the environment of a veterinary medical teaching hospital and to examine specific factors, such as use of antibiotics and/or immunosuppressive therapy, that may influence the risk for infection.
Materials and methods
Animals. Animals studied were part of the clinical population of the UC Veterinary Medical Teaching Hospital. Fecal specimens for culture were collected by rectal swabs from 245 cats Ն 1 yr of age during a 6-mo period in 1996-1997. Samples were collected from in-and outpatients of the hospital. An inpatient was defined as a cat admitted to the hospital and spending at least 24 hr in a ward. Outpatient animals did not stay overnight in the hospital, although they may have spent part of a day in a hospital ward. Fecal samples were collected from clinically healthy cats (n ϭ 56) examined in the outpatient (well-cat) clinic and from cats (n ϭ 189) examined or hospitalized for a variety of medical problems. Additional cats (n ϭ 49) from a university specific-pathogen-free (SPF) cat facility were also examined, including 24 healthy cats and 25 cats involved in an acute outbreak of diarrhea following a plumbing malfunction in this SPF facility. These cats ranged in age from 6 mo to 5 
yr and had all spent Ն6 mo in the experimental animal facility.
Isolation and identification of C. difficile from stool samples. The laboratory methods used for isolation and detection of toxigenic strains of C. difficile have been previously described 7, 8 and adapted to a veterinary setting. 15, 21 Rectal swabs were placed in brain-heart infusion medium a and immediately frozen at Ϫ20 C until handled in the laboratory. Within 7 days, the inoculated broth was thawed, incubated anaerobically at 37 C for 24 hr, and then streaked on the selective medium cycloserine-cefoxitin-fructose agar 6 and incubated anaerobically for 36-48 hr at 37 C. Colonies were identified as C. difficile by characteristic odor, colony morphology, 14, 17 and a latex agglutination test, b which detects a metabolic enzyme, glutamate dehydrogenase. 14 DNA extraction and amplification of toxin genes. DNA was extracted from isolated colonies as described elsewhere. 23 A single colony of each culture was scraped with an inoculating loop into a 0.6-ml microcentrifuge tube containing 100 l of sterile water. After boiling for 10 min, the sample was centrifuged at 5,000 ϫ g for 3 min to remove cellular debris. DNA in the supernatant was quantitated as described previously. 7 The sequences of the oligonucleotide primers and probes used for amplification of toxin A and B gene sequences are shown in Table 1 . A modification of the polymerase chain reaction (PCR) 16 was used for amplification with a thermostable DNA polymerase (Taq polymerase c ). The PCR profile used for amplification of the toxin genes was previously described. 22 Genotyping of C. difficile isolates was done using the arbitrary primer T-7 as previously described. 19, 23 Detection of amplified products. Amplification products from the toxicity genes were resolved on 2% agarose gels, stained with ethidium bromide, and photographed under ultraviolet light. For arbitrarily primed PCR (AP-PCR), DNA banding patterns were visualized and compared by analysis of 12 l of the AP-PCR amplification product in a 1.5% agarose gel. Banding patterns were analyzed using fingerprinting software. d Southern blot analysis. A nonradioactive method employing horseradish peroxidase, a biotin labeled oligomer, and an enzyme chemiluminescence detection system e was used in the Southern blot analysis, as previously described. 7
Results
Fecal swabs were collected from 245 cats in the veterinary medical teaching hospital and from 49 cats in a research SPF cat facility on the campus of UC Davis. Twenty-three (9.4%) of the cats from the hospital harbored C. difficile, as determined by culture on selective media and identification by latex agglutination test. Toxin A and B sequences were identified in 8/23 isolates and were confirmed as a toxin gene by Southern blot hybridization. Amplification products and Southern blot analysis of selected isolates are shown in Fig. 1 . All of the cats colonized with toxigenic C. difficile had 1 or more risk factors previously identified with C. difficile-associated diarrhea in human patients. The clinical features of these 8 cats are summarized in Table 2 . The 15 cats identified as harboring nontoxigenic C. difficile were also derived from the group of 189 cats examined for a variety of medical conditions, but C. difficile was not isolated from any of the 56 healthy cats from the outpatient clinic of the hospital nor from the cats housed at the experimental SPF cat facility.
The average age for cats carrying C. difficile in their stools (including toxigenic and nontoxigenic strains) was 9.5 years. There were 13 male and 10 female cats. Eighteen of the cats were inpatients and 5 were outpatients. The average length of stay in hospital for inpatients was 6.2 days. Ten of the 23 cats had gastrointestinal signs. Of the 10 cats tested for feline leukemia virus and feline immunodeficiency virus, only 1 cat was positive (for both viruses), a cat with malignant lymphoma affecting the anterior mediastinum. Eighteen of 23 cats were receiving 1 or more antibiotics at the time of testing; amoxicillin-clavulanic acid (8) , metronidazole (4), ampicillin (4), enrofloxacin (4), and amoxicillin (4) . Seven of the 23 cats were receiving 1 or more anticancer drugs for malignant lymphoma (5), multiple myeloma (1), or mast cell sarcoma (1) . Eleven of 23 cats were receiving corticosteroids. Twenty-one of 23 cats were being treated for chronic diseases, including cancer, chronic renal insufficiency, hepatic lipidosis, diabetes mellitus, pemphigus, or myeloid dyscrasias. All of these cats had been in and out of the teaching hospital and other veterinary clinics for weeks or months prior to testing for C. difficile, and all had been treated previously with antibiotics. Two cats harboring the organism had less severe illness; 1 was hospitalized and being managed medically (amoxicillin) and surgically for aural polyps and the other was an out-patient with diarrhea, also being treated with amoxicillin. AP-PCR demonstrated 5 different C. difficile strain types (Fig. 2) . One of the most prominent types, type 4 (30.4% of the isolates), was also recovered from a drain in 1 of the wards where cats were housed. This drain and others in the facility were culture negative for C. difficile upon subsequent culturing over a 3-month period. Type 2 represented 47.8% of all isolates.
Discussion
The ecology of C. difficile in nature is complex; it appears to be a normal component of the indigenous mammalian colonic flora, particularly in young individuals. 25 Reported carriage rates in healthy human adults are variable, ranging in some studies from 0-3% to 15%. 5 Although fecal carriage of C. difficile was not detected in healthy adult cats in the present study, 1 limitation of the study was that only a single fecal swab was obtained from each animal; more frequent testing may have resulted in higher rates of positive animals.
Clostridium difficile has been previously isolated from a variety of species in veterinary settings. Isolation rates of 6-40% have been described in the dog. 3, 18, 21, 24 This wide range is likely a reflection of different populations of animals and differences in testing procedures. Both toxigenic and nontoxigenic strains of C. difficile have been described in the dog. 21 Dogs may harbor the organism asymptomatically, although it can also cause diarrhea. 2 One study of cats from Germany revealed the presence of nontoxigenic strains of C. difficile in animals with and without gastrointestinal signs at rates of 9% and 6.7%, respectively. 24 Of 100 cats without diarrhea tested in New Zealand, 2% harbored C. difficile and 1 of those isolates contained toxin A. 1 Twenty cats without diarrhea from England were tested in another study, and 6 (30%) carried C. difficile. 3 Virulent or pathogenic strains of the organism were demonstrated in that study using the hamster model of antibiotic-associated enterocolitis. A study of 21 cats without diarrhea from Australia (cats were sampled repeatedly) revealed 39.5% fecal carriage of C. difficile, and both toxigenic and nontoxigenic isolates were recovered. 18 Specific tests for C. difficile toxins used in the diagnostic laboratory include cell culture, which relies on the presence of biologically active toxin, and an enzyme-linked immunosorbent assay, which detects immunologically active toxin that may or may not be biologically active. 14 PCR techniques have been introduced to the diagnostic laboratory and have the advantage of being as much as 100-fold more sensitive than anaerobic culture, detecting as few as 10 cells in 1 g of stool. 7 The PCR method can detect and discriminate between toxigenic and nontoxigenic strains of the organism 8, 22 and has been used to detect fecal carriage of C. difficile in dogs, horses, and cats. 15, 25 In the present study, cats with fecal carriage of nontoxigenic strains of C. difficile were not given specific therapy. The significance of recovering nontoxigenic C. difficile in asymptomatic human patients is uncertain because the organism is a normal component of 4, 9, 12, 17: blank. the colonic microflora in some individuals. 25 Of the 8 cats colonized with toxigenic C. difficile, 4 were treated with metronidazole, resulting in recovery from diarrhea and negative fecal culture on subsequent testing for C. difficile. One additional cat had chronic, intermittent diarrhea and 3 consecutive positive stools samples over an 8-week period despite metronidazole therapy. Because the cost for vancomycin was prohibitive for the owner, the cat was given yeast (Saccharomyces boulardii 0.5 g/day, divided) for 4 weeks, during which time the diarrhea ceased and the ensuing fecal test for C. difficile was negative. One of the later C. difficile isolates from this cat was sensitive in vitro to metronidazole, d suggesting that the cat was either inadequately treated with metronidazole or that it had been reinfected. Because there have been few descrip-tions of metronidazole therapy for C. difficile in cats, it is unknown whether chronic carriers or recurrences following treatment will emerge as a clinical problem, both of which are extremely important concerns in human patients. 12 AP-PCR allowed identification of different genotypes of C. difficile within the hospital population of cats tested. These findings are consistent with those in human hospitals, where multiple strains of C. difficile are usually encountered; multiple strains are often isolated during outbreaks of C. difficile-associated diarrhea. 4, 25 The demonstration of C. difficile in a hospital drain of the same genotype as that isolated from cats housed in that ward underscores the potential role of environmental contamination in bacterial transmission. Spores of C. difficile are stable in the environment for many months, and contamination of a variety of surfaces may occur, particularly in areas where patients with C. difficile have been treated. 5 A relatively small number of individual cats were identified in this study with toxigenic or nontoxigenic strains of C. difficile; therefore, statistical analyses of factors that may influence risk for fecal carriage of the organism could not be done. All cats colonized with C. difficile had 1 or more of the risk factors known to influence susceptibility to infection in human patients in clinical settings, including prolonged stay in hospital, immune suppression, and/or chronic disease requiring antibiotic and/or immunosuppressive therapy. However, a larger number of cats sampled during the same time period and with the same risk factors were negative for C. difficile.
Clostridium difficile may be present in animal patients, is likely to be widely distributed throughout animal populations and clinical environments, and may play a role in clinical disease. Specific testing for the presence of C. difficile is advised for those patients with gastrointestinal signs for which other causes have not been established. 
Sources and manufacturers

